The year in review: A Mugglehead roundup

The year 2025 in review: A Mugglehead roundup

Blink and 2025 is going to be over. Pop the cork. Hallelujah.

The year was defined by a weird mix of volatility, breakthroughs, and sharp reminders of how fast technology, markets, and medicine can shift. Precious metals surged on global uncertainty as wars and violence made investors head for safe haven assets. Medical diagnostics and psychedelic therapies incorporated artificial intelligence and inched towards the mainstream.

Investor behavior told a similar story. In periods of ...

Continue Reading →

Ibogaine and 5-MeO-DMT – Christopher Ryan, PHD discusses with Crossroads Ibogaine



Crossroad’s own Martin Polanco and Maria Teresa talk on Christopher Ryan, PhD’s podcast talking about Crossroads Ibogaine treatment and 5-MeO-DMT.

Ibogaine is not a scheduled drug in Mexico which allows us to treat patients with Ibogaine. DMT falls under this same category. Ibogaine works in the brain to help eliminate withdrawals in addicts. This is what make Ibogaine such an effective treatment for addiction.

We follow up our Ibogaine ...

Continue Reading →
UA-77446339-1